Company Filing History:
Years Active: 2023-2025
Title: Innovations of Xiaoshen Ma in Cancer Therapeutics
Introduction
Xiaoshen Ma is a prominent inventor based in Boston, MA, known for his significant contributions to the field of cancer therapeutics. He holds three patents that focus on small molecule inhibitors targeting the KRAS G12C mutant, a critical area of research in oncology.
Latest Patents
Xiaoshen Ma's latest patents include innovative compounds designed to inhibit the G12C mutant of the Kirsten rat sarcoma (KRAS) protein. These compounds, represented by Formula (I) or their pharmaceutically acceptable salts, are expected to serve as therapeutic agents for cancer treatment. The patents also encompass pharmaceutical compositions that incorporate these compounds and outline methods for their use in cancer therapy and prophylaxis.
Career Highlights
Xiaoshen Ma is currently associated with Merck Sharp & Dohme Corporation, where he continues to advance his research in cancer therapeutics. His work is pivotal in developing new treatment options for patients suffering from various forms of cancer.
Collaborations
Some of Xiaoshen Ma's notable coworkers include Indu T Bharathan and Symon Gathiaka, who collaborate with him in his research endeavors.
Conclusion
Xiaoshen Ma's innovative work in developing small molecule inhibitors for cancer treatment highlights his commitment to advancing medical science. His contributions are expected to have a lasting impact on cancer therapeutics and patient care.